0000950170-23-029609.txt : 20230623
0000950170-23-029609.hdr.sgml : 20230623
20230623160800
ACCESSION NUMBER: 0000950170-23-029609
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230615
FILED AS OF DATE: 20230623
DATE AS OF CHANGE: 20230623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HASTINGS DAVID C
CENTRAL INDEX KEY: 0001237401
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36365
FILM NUMBER: 231037740
MAIL ADDRESS:
STREET 1: C/O ARBUTUS BIOPHARMA
STREET 2: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCYNEXIS INC
CENTRAL INDEX KEY: 0001178253
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562181648
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 EVERTRUST PLAZA
STREET 2: 13TH FLOOR
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302-6548
BUSINESS PHONE: 201-884-5485
MAIL ADDRESS:
STREET 1: 1 EVERTRUST PLAZA
STREET 2: 13TH FLOOR
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302-6548
4
1
ownership.xml
4
X0407
4
2023-06-15
0001178253
SCYNEXIS INC
SCYX
0001237401
HASTINGS DAVID C
1 EVERTRUST PLAZA
13TH FLOOR
JERSEY CITY
NJ
07302-6548
true
false
Common Stock
2023-06-15
4
A
false
10000
0.00
A
23183
D
One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.
/s/ Robert F. Joyce Jr.
2023-06-23